情景分析法在新药研发价值评估中的应用研究
[Abstract]:The 13 th-5-year-plan classifies the pharmaceutical industry as one of the key development industries. Research and development of new drugs is the driving force of the development of pharmaceutical industry, and the transformation of research and development results depends on the reliable measurement and evaluation of future benefits. Therefore, the evaluation of new drug research and development constitutes an important part of the development of the pharmaceutical industry. Evaluation of the value of new drug research and development has become the current focus of the industry. This paper focuses on the evaluation methods involved in the evaluation process of new drug research value. There are mainly three methods used in asset evaluation, namely, market approach, income approach and cost method. Although the traditional methods have their own characteristics, the traditional methods can not play a good role in the face of some specific objects, such as the research and development of new drugs. There is a weak symmetry in the research results of R & D cost in cost method, which leads to the difference of the actual value of the evaluation results. There is a lack of comparable cases in market law because the basis for comparable cases in market law is rather weak. There is uncertainty about the value of new drug research and development in the income approach, which leads to the traditional method can not be applied to the evaluation of this kind of assets. Based on the analysis of the essence of scenario analysis, this paper mainly discusses the application of decision tree method, constructs the measuring model of this method, and explains the selection of parameters in detail. Special discount rate, success rate, free cash flow and the division of stage time are obtained. A full demonstration is made. In the second half of this paper, a practical case is used to explain the concrete application of the method by combining the theory with the practical application. The conclusion of this paper is that scenario analysis can be used to evaluate the value of new drug research and development. There are some limitations on the application of this method. This kind of problem will be the content of the following research in this paper.
【学位授予单位】:江西财经大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:F406.7;F426.72
【参考文献】
相关期刊论文 前10条
1 闫凯;李认书;周水平;李云飞;孙鹤;;实物期权法在新药研发项目价值评估中的应用[J];项目管理技术;2012年09期
2 王知津;周鹏;韩正彪;;基于情景分析法的企业危机发展预测[J];图书馆论坛;2010年06期
3 朱燕萍;;决策树法在企业决策中的应用[J];企业导报;2009年02期
4 倪亚飞;;基于二叉树的实物期权法在新药研发中的应用研究[J];技术与创新管理;2009年01期
5 王茜;;基于实物期权理论的医药生物企业研发投资特性分析[J];科学学与科学技术管理;2008年02期
6 曹丽;;浅析资本预算中的净现值法[J];财会月刊;2007年27期
7 赵修卫;舒文静;;实物期权法与净现值法在R&D项目评价中的比较[J];中国资产评估;2006年09期
8 赵振武;唐万生;;模糊实物期权理论在风险投资项目价值评价中的应用[J];北京理工大学学报(社会科学版);2006年01期
9 于红霞;钱荣;;解读未来发展不确定性的情景分析法[J];未来与发展;2006年02期
10 许群英;曾勇;蔡强;;实物期权在新药开发中的应用[J];运筹与管理;2005年06期
相关博士学位论文 前1条
1 杨莉;药物经济学评价需求、方法与指南研究[D];复旦大学;2004年
相关硕士学位论文 前2条
1 周丽丽;模糊实物期权在R&D项目评价中的应用[D];华中科技大学;2012年
2 郭军;基于模糊实物期权的风险投资决策研究[D];南京航空航天大学;2008年
,本文编号:2188757
本文链接:https://www.wllwen.com/gongshangguanlilunwen/2188757.html